Access
To read this story in full you will need to login or make a payment (see right).
News and Views
Nature 434, 829-830 (14 April 2005) | doi:10.1038/434829a; Published online 13 April 2005
Open Innovation Challenges
-
Novel Approaches to Protecting Maize from Insect Damage
The Seeker is looking for novel approaches to protecting maize from insect damage. This Challenge re...
-
Direct Molecular Detection of Proteins and Nucleic Acids
This Challenge is looking for novel approaches to protein and nucleic acid detection. This is an Id...
nature jobs
Chair, Department of Informatic Medicine and Personalized Health
- University of Missouri-Kansas City
- Kansas City, Missouri, USA
Assistant Manager-Pharma / CRO-Global Strategic Sourcing
- Varda Biotech
- Mumbai India
Medicine: Aborting the birth of cancer
Ashok R. Venkitaraman1
Abstract
Can cells sense and stop uncontrolled division driven by cancer-promoting stimuli? Perhaps so, given evidence that aberrant division can trigger the cellular response to DNA damage — blocking growth — at early stages in human cancer.
Why human cancer is not more frequent remains a mystery, given our trillions of susceptible cells, each with many genes subject to mutations that could ignite uncontrolled cell proliferation. One intuitive concept — which has been in the spotlight for decades — is that normal cells can somehow perceive and arrest aberrant cycles of cell division that are triggered by cancer-promoting (oncogenic) stimuli, such as the inappropriate activation of oncogenes.
-
Ashok R. Venkitaraman is in the Cancer Research UK Department of Oncology and the Medical Research Council Cancer Cell Unit, University of Cambridge, Hills Road, Cambridge
CB2 2XZ, UK.
e-mail: Email: arv22cam.ac.uk
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Isolation of the human PEX12 gene, mutated in group 3 of the peroxisome biogenesis disordersNature Genetics Letter (01 Apr 1997)

